← Back to Patent Explorer
US4226853A Expired / Lapsed US ⏱️ 0.0 years remaining

Formalinized allergen-containing substances and production thereof

Assignee: Individual
•
Filing: 1975-02-18
•
Granted: 1980-10-07
•
Expires: 1995-02-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to the production of formaldehyde treated allergens suitable for the immunotherapy (desensitization) of individuals suffering from allergies of the immediate type. These formalinized allergen-containing materials are also useful to induce formation of antibody in mammals which cross reacts with the native allergen-containing materials.

Inventors

  • 👤 David G. Marsh

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 05:48
CPC Classifications
A; A61; A61K; A61K39/00; A61K39/35; A61K39/36

Claims Analysis

Total Claims: 41
Claim 1
Independent Claim 199 words
A process for producing a formalinized allergen of low allergenic activity in allergic humans and which is capable of inducing in mammals the formation of blocking antibody against the native allergen in significant concentration, comprising: (1) extracting an allergen-containing material with an aqueous solution; (2) removing essentially all of the low molecular weight non-allergenic substances from the soluble part of the said extract to leave the allergen-containing materials in said solution; (3) adding formaldehyde to the said solution of allergen-containing materials to give a concentration of formaldehyde from about 0.06 M to 5.0 M; (4) treating the aqueous extract of material containing said allergens with said formaldehyde solution in a non-phenolic environment at a temperature from about the freezing point of the incubation mixture up to about 40° C.; and (5) incubating the same at a temperature below that which the allergen undergoes substantial heat denaturation and generally from about the freezing point of the incubation mixture up to about 40° C. until the substantial formation of inter- or intramolecular methylene bridge linkages occurs in said solution and the allergenic determinant groups are modified to result in substantial reduction of allergenic properties while largely retaining the desired immunizing properties.
Claim 2
Dependent Claim 199 words
A process for producing a formalinized allergen of low allergenic activity in allergic humans and which is capable of inducing in mammals the formation of blocking antibody against the native allergen in significant concentration, comprising: (1) extracting an allergen-containing material with an aqueous solution; (2) removing essentially all of the low molecular weight non-allergenic substances from the soluble part of the said extract to leave the allergen-containing materials in said solution; (3) adding formaldehyde to the said solution of allergen-containing materials to give a concentration of formaldehyde from about 0.06 M to 5.0 M; (4) treating the aqueous extract of material containing said allergens with said formaldehyde solution in a non-phenolic environment at a temperature from about the freezing point of the incubation mixture up to about 40° C.; and (5) incubating the same at a temperature below that which the allergen undergoes substantial heat denaturation and generally from about the freezing point of the incubation mixture up to about 40° C. until the substantial formation of inter- or intramolecular methylene bridge linkages occurs in said solution and the allergenic determinant groups are modified to result in substantial reduction of allergenic properties while largely retaining the desired immunizing properties.
Claim 3
Dependent Claim 17 words
The process of claim 1 wherein the incubation is subsequently extended with the addition of more formaldehyde.
Claim 4
Dependent Claim 37 words
A process of claim 1 wherein there is present along with said dilute formaldehyde solution at least one additive selected from the group consisting of 1,4-diaminobutane, lysine, ornithine, 1,5-diamino-pimelic acid, arginine, adipamide, aspartic acid, serine and alanine.
Claim 5
Dependent Claim 18 words
The process of claim 1 wherein the allergen-containing material is an aqueous extract of a grass pollen substance.
Claim 6
Dependent Claim 17 words
The process of claim 1 wherein the allergen-containing material contains a Group I grass pollen allergen preparation.
Claim 7
Dependent Claim 18 words
The process of claim 1 wherein the allergen-containing material is an aqueous extract of a weed pollen substance.
Claim 8
Dependent Claim 14 words
The process of claim 1 wherein the allergen-containing material contains ragweed pollen's Antigen E.
Claim 9
Dependent Claim 18 words
The process of claim 1 wherein the allergen-containing material is an aqueous extract of a tree pollen substance.
Claim 10
Dependent Claim 20 words
The process of claim 1 wherein the allergen-containing material is an aqueous extract containing house dust mites or their residues.
Claim 11
Dependent Claim 14 words
The process of claim 1 wherein the allergen-containing material is a purified allergen preparation.
Claim 12
Dependent Claim 188 words
A process for producing a formalinized allergen of low allergenic activity in allergic humans and which is capable of inducing in mammals the formation of blocking antibody against the native allergen in significant concentration, comprising: (1) extracting an allergen-containing material with an aqueous solution; (2) removing essentially all of the low molecular weight non-allergenic substances from the soluble part of the said extract to leave the allergen-containing materials in said solution; (3) adding formaldehyde to the said solution of allergen-containing materials to give a concentration of formaldehyde from about 0.06 M to 4.0 M; (4) treating the aqueous extract of material containing said native allergen with said formaldehyde solution in a non-phenolic environment at a temperature from about 15° C. to about 32° C.; and (5) incubating the same at a temperature below that which the allergen undergoes substantial heat denaturation and generally from about 15° C. to about 32° C. until the substantial formation of inter- or intramolecular methylene bridge linkages occurs in said solution and the allergenic determinant groups are modified to result in substantial reduction of allergenic properties while largely retaining the desired immunizing properties.
Claim 13
Dependent Claim 188 words
A process for producing a formalinized allergen of low allergenic activity in allergic humans and which is capable of inducing in mammals the formation of blocking antibody against the native allergen in significant concentration, comprising: (1) extracting an allergen-containing material with an aqueous solution; (2) removing essentially all of the low molecular weight non-allergenic substances from the soluble part of the said extract to leave the allergen-containing materials in said solution; (3) adding formaldehyde to the said solution of allergen-containing materials to give a concentration of formaldehyde from about 0.06 M to 4.0 M; (4) treating the aqueous extract of material containing said native allergen with said formaldehyde solution in a non-phenolic environment at a temperature from about 15° C. to about 32° C.; and (5) incubating the same at a temperature below that which the allergen undergoes substantial heat denaturation and generally from about 15° C. to about 32° C. until the substantial formation of inter- or intramolecular methylene bridge linkages occurs in said solution and the allergenic determinant groups are modified to result in substantial reduction of allergenic properties while largely retaining the desired immunizing properties.
Claim 14
Dependent Claim 37 words
The process of claim 11 wherein there is present along with said dilute formaldehyde solution at least one additive selected from the group consisting of 1,4-diaminobutane, lysine, ornithine, 1,5-diamino-pimelic acid, arginine, adipamide, aspartic acid, serine and alanine.
Claim 15
Dependent Claim 18 words
The process of claim 11 wherein the allergen-containing material is an aqueous extract of a grass pollen substance.
Claim 16
Dependent Claim 17 words
The process of claim 11 wherein the allergen-containing material contains a Group I grass pollen allergen preparation.
Claim 17
Dependent Claim 18 words
The process of claim 11 wherein the allergen-containing material is an aqueous extract of a weed pollen substance.
Claim 18
Dependent Claim 14 words
The process of claim 11 wherein the allergen-containing material contains ragweed pollen's Antigen E.
Claim 19
Dependent Claim 18 words
The process of claim 11 wherein the allergen-containing material is an aqueous extract of a tree pollen substance.
Claim 20
Dependent Claim 20 words
The process of claim 11 wherein the allergen-containing material is an aqueous extract containing house dust mites or their residues.
Claim 21
Dependent Claim 14 words
The process of claim 11 wherein the allergen-containing material is a purified allergen preparation.
Claim 22
Dependent Claim 196 words
A formalinized allergen of low allergenic activity in allergic humans and which is capable of inducing in mammals the formation of blocking antibody against the native allergen in significant concentration, prepared by: (1) extracting an allergen-containing material with an aqueous solution; (2) removing essentially all of the low molecular weight non-allergenic substances from the soluble part of the said extract to leave the allergen-containing materials in said solution; (3) adding formaldehyde solution to the said solution of allergen-containing materials to give a concentration of formaldehyde from about 0.06 M to 5.0 M; (4) treating the aqueous extract of material containing said allergens with said formaldehyde solution in a non-phenolic environment at a temperature from about the freezing point of the incubation mixture up to about 40° C.; and (5) incubating the same at a temperature below that which the allergen undergoes substantial heat denaturation and generally from about the freezing point of the incubation mixture up to about 40° C. until substantial formation of inter- or intramolecular methylene bridge linkages occur in said solution and the allegenic determinant groups are modified to result in substantial reduction of allergenic properties while largely retaining the desired immunizing properties.
Claim 23
Dependent Claim 196 words
A formalinized allergen of low allergenic activity in allergic humans and which is capable of inducing in mammals the formation of blocking antibody against the native allergen in significant concentration, prepared by: (1) extracting an allergen-containing material with an aqueous solution; (2) removing essentially all of the low molecular weight non-allergenic substances from the soluble part of the said extract to leave the allergen-containing materials in said solution; (3) adding formaldehyde solution to the said solution of allergen-containing materials to give a concentration of formaldehyde from about 0.06 M to 5.0 M; (4) treating the aqueous extract of material containing said allergens with said formaldehyde solution in a non-phenolic environment at a temperature from about the freezing point of the incubation mixture up to about 40° C.; and (5) incubating the same at a temperature below that which the allergen undergoes substantial heat denaturation and generally from about the freezing point of the incubation mixture up to about 40° C. until substantial formation of inter- or intramolecular methylene bridge linkages occur in said solution and the allegenic determinant groups are modified to result in substantial reduction of allergenic properties while largely retaining the desired immunizing properties.
Claim 24
Dependent Claim 37 words
The product of claim 20 wherein there is present along with said dilute formaldehyde solution at least one additive selected from the group consisting of 1,4-diamino-butane, lysine, ornithine, 1,5-diamino-pimelic acid, arginine, adipamide, aspartic acid, serine and alanine.
Claim 25
Dependent Claim 18 words
The product of claim 20 wherein the allergen-containing material is an aqueous extract of a grass pollen substance.
Claim 26
Dependent Claim 17 words
The product of claim 20 wherein the allergen-containing material contains a Group I grass pollen allergen preparation.
Claim 27
Dependent Claim 18 words
The product of claim 20 wherein the allergen-containing material is an aqueous extract of a weed pollen substance.
Claim 28
Dependent Claim 14 words
The product of claim 20 wherein the allergen-containing material contains ragweed pollen's Antigen E.
Claim 29
Dependent Claim 18 words
The product of claim 20 wherein the allergen-containing material is an aqueous extract of a tree pollen substance.
Claim 30
Dependent Claim 20 words
The product of claim 20 wherein the allergen-containing material is an aqueous extract containing house dust mites or their residues.
Claim 31
Dependent Claim 14 words
The product of claim 20 wherein the allergen-containing material is a purified allergen preparation.
Claim 32
Dependent Claim 184 words
A formalinized allergen of low allergenic activity in allergic humans and which is capable of inducing in mammals the formation of blocking antibody against the native allergen in significant concentration, prepared by: (1) extracting an allergen-containing material with an aqueous solution; (2) removing essentially all of the low molecular weight non-allergenic substances from the soluble part of the said extract to leave the allergen-containing materials in said solution; (3) adding formaldehyde solution to the said solution of allergen-containing materials to give a concentration of formaldehyde from about 0.06 M to 4.0 M (4) treating the aqueous extract of material containing said allergens with said formaldehyde solution in a non-phenolic environment at a temperature from about 15° C. to about 32° C.; and (5) incubating the same at a temperature below that which the allergen undergoes substantial heat denaturation and generally from about 15° C. to about 32° C. until substantial formation of inter- or intramolecular methylene bridge linkages occur in said solution and the allergenic determinant groups are modified to result in substantial reduction of allergenic properties while largely retaining the desired immunizing properties.
Claim 33
Dependent Claim 184 words
A formalinized allergen of low allergenic activity in allergic humans and which is capable of inducing in mammals the formation of blocking antibody against the native allergen in significant concentration, prepared by: (1) extracting an allergen-containing material with an aqueous solution; (2) removing essentially all of the low molecular weight non-allergenic substances from the soluble part of the said extract to leave the allergen-containing materials in said solution; (3) adding formaldehyde solution to the said solution of allergen-containing materials to give a concentration of formaldehyde from about 0.06 M to 4.0 M (4) treating the aqueous extract of material containing said allergens with said formaldehyde solution in a non-phenolic environment at a temperature from about 15° C. to about 32° C.; and (5) incubating the same at a temperature below that which the allergen undergoes substantial heat denaturation and generally from about 15° C. to about 32° C. until substantial formation of inter- or intramolecular methylene bridge linkages occur in said solution and the allergenic determinant groups are modified to result in substantial reduction of allergenic properties while largely retaining the desired immunizing properties.
Claim 34
Dependent Claim 37 words
The product of claim 29 wherein there is present along with said dilute formaldehyde solution at least one additive selected from the group consisting of 1,4-diaminobutane, lysine, ornithine, 1,5-diamino-pimelic acid, arginine, adipamide, aspartic acid, serine and alanine.
Claim 35
Dependent Claim 18 words
The product of claim 29 wherein the allergen-containing material is an aqueous extract of a grass pollen substance.
Claim 36
Dependent Claim 17 words
The product of claim 29 wherein the allergen-containing material contains a Group I grass pollen allergen preparation.
Claim 37
Dependent Claim 18 words
The product of claim 29 wherein the allergen-containing material is an aqueous extract of a weed pollen substance.
Claim 38
Dependent Claim 14 words
The product of claim 29 wherein the allergen-containing material contains ragweed pollen's Antigen E.
Claim 39
Dependent Claim 18 words
The product of claim 29 wherein the allergen-containing material is a aqueous extract of a tree pollen substance.
Claim 40
Dependent Claim 20 words
The product of claim 29 wherein the allergen-containing material is an aqueous extract containing house dust mites or their residues.
Claim 41
Dependent Claim 14 words
The product of claim 29 wherein the allergen-containing material is a purified allergen preparation.

References Cited (Backward Citations)

US2019803A Cited
US2150131A Cited
US3135662A Cited
FR1320769A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-10-07 1984-04-07 1984-10-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-10-07 1988-04-07 1988-10-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-10-07 1992-04-07 1992-10-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag